Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study aims to evaluate the analgesic efficacy and safety of meloxicam injection in subjects with moderate-to-severe pain following abdominal surgery. The primary efficacy endpoint is the summed pain intensity difference over 24 hours ( SPID24)
Epistemonikos ID: 3a695dab1be4ffb0eaaf6abc5b4731c2219450c2
First added on: Apr 02, 2025